CADTH Canadian Drug Expert Committee final recommendation Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection

CADTH Canadian Drug Expert Committee final recommendation Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication HIV-1 infection

Bibliographic Details
Main Author: Canadian Agency for Drugs and Technologies in Health (author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Format: eBook
Language:Inglés
Published: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health 2016.
Subjects:
Pharmacology, Experimental.
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820284906719
Description
Physical Description:1 online resource (5 pages)

Similar Items